The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Active Implantable Medical Devices Market By 2030 Starting From Its 2026 Size?
The active implantable medical devices market has experienced robust growth in recent years. It is anticipated to expand from $27.95 billion in 2025 to $30.51 billion in 2026, showing a compound annual growth rate (CAGR) of 9.1%. This historical growth can be attributed to the increasing prevalence of cardiovascular and neurological disorders, the early adoption of pacemakers and neurostimulators, advancements in battery technologies, improvements in implant biocompatibility, and growing clinician familiarity with implantable systems.
The active implantable medical devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a size of $42.81 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. The projected growth during this period is fueled by several factors, including the proliferation of remote patient monitoring solutions, the growing need for tailored implantable therapies, the increased adoption of AI-enabled diagnostics, the expanding elderly population needing chronic care, and innovations in wireless power and communication technologies. Key trends expected in the forecast period encompass the greater integration of smart and connected implantable devices, an increasing uptake of miniaturized electronic components, the expanding application of data-driven therapeutic monitoring, the broadening scope of long-term implantable therapies, and a heightened emphasis on the durability and dependability of these devices.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8938&type=smp
Which Market Drivers Are Supporting The Expansion Of The Active Implantable Medical Devices Market?
The rising prevalence of cardiovascular diseases is anticipated to drive the expansion of the active implantable medical devices market in the foreseeable future. Cardiovascular disease (CVD) refers to any medical condition impacting the heart or blood vessels. It is commonly associated with the formation of fatty deposits within the arteries (atherosclerosis) and an elevated risk of blood clots. Active implantable medical devices are utilized to regulate or monitor irregular heartbeats in individuals experiencing specific heart rhythm issues or heart failure. The growing number of elderly individuals has also contributed to the demand for active implantable medical devices. For instance, in September 2025, according to the British Heart Foundation, a UK-based charity, more than 7.6 million people across the UK—including over 4 million men and more than 3.6 million women—are living with cardiovascular disease. Projections indicate that, driven by an aging population and enhanced survival rates, the number of affected individuals could increase by approximately 1 million by 2030 and by around 2 million by 2040. Therefore, the increase in cardiovascular diseases is a key factor propelling the growth of the active implantable medical devices market.
Which Segment Categories Define The Active Implantable Medical Devices Market?
The active implantable medical devices market covered in this report is segmented –
1) By Product Type: Cardiac Pacemakers, Implantable Cardioverter Defibrillators (ICD), Nerve Simulators, Cochlear Implants, Ventricular Assist Devices, Other Products
2) By Application: Cardiovascular, Neurological, Hearing Impairment, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Cardiac Pacemakers: Single Chamber Pacemakers, Dual Chamber Pacemakers, Biventricular Pacemakers
2) By Implantable Cardioverter Defibrillators (ICD): Transvenous ICDs, Subcutaneous ICDs
3) By Nerve Stimulators: Spinal Cord Stimulators, Peripheral Nerve Stimulators, Deep Brain Stimulators
4) By Cochlear Implants: Single-Electrode Cochlear Implants, Multichannel Cochlear Implants
5) By Ventricular Assist Devices: Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD)
6) By Other Products: Neurostimulators for Pain Management, Implantable Drug Delivery Systems, Implantable Blood Pressure Monitors
What Major Market Trends Are Driving Changes In The Active Implantable Medical Devices Market?
Leading entities within the active implantable medical device market are prioritizing the creation of technological innovations, including implantable PEEK filament, to boost customization, better patient results, and optimize manufacturing workflows. This specialized material, implantable PEEK filament, is engineered for manufacturing medical implants via additive manufacturing techniques. An example of this trend occurred in March 2023, when Invibio, a U.K.-based supplier of high-performance implantable biomaterials, introduced PEEK-OPTIMA AM filament. Composed of implantable polyetheretherketone (PEEK) filament, PEEK-OPTIMA AM filament is recognized for its biocompatibility and mechanical strength, rendering it appropriate for implantable medical devices. Optimized for fused filament fabrication (FFF), this novel filament intends to improve the manufacturing of medical devices. Its design is precisely tailored for 3D printing uses within the medical sector.
Who Are The Top Companies Competing In The Active Implantable Medical Devices Market?
Major companies operating in the active implantable medical devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co KG, LivaNova PLC, Cochlear Limited, MED-EL Medical Electronics, Sonova Holding AG, NeuroPace Inc, NEVRO Corp, Axonics Inc, Aleva Neurotherapeutics SA, MicroTransponder Inc, Shree Pacetronix, Berlin Heart GmbH, Jarvik Heart Inc, Blackrock Neurotech, Nurotron Biotechnology Co Ltd, CARMAT SA, Precision Neuroscience, Pins Medical, Lepu Medical Technology Co Ltd, LifeTech Scientific
Read the full active implantable medical devices market report here:
How Is The Active Implantable Medical Devices Market Distributed Across Key Geographic Regions?
North America was the largest region in the active implantable medical devices market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the active implantable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Active Implantable Medical Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8938&type=smp
Browse Through More Reports Similar to the Global Active Implantable Medical Devices Market 2026, By The Business Research Company
Smart Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-implants-global-market-report
Implantable Drug Delivery Devices Market Report 2026
Microelectronic Medical Implants Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model